首页> 外国专利> Combination therapy for topical application in the treatment of age-related macular degeneration and ocular hypertension

Combination therapy for topical application in the treatment of age-related macular degeneration and ocular hypertension

机译:局部用药联合治疗老年性黄斑变性和高眼压症

摘要

A topical drug composition for the treatment of age-related maculopathy, age-rlated macular degeneration, ocular hypertension, glaucoma or other eye disease resulting from increased intraocular pressure comprising a solution of anabolic androgenic agent and 17-β-estradiol suspended or dissolved in a suitable ophthalmic vehicle is disclosed. In the preferred embodiment, 17-β-estradiol, or its esters, is in a lipid vehicle or 17-β-estradiol-3-phosphate, or other esters of 17-β-estradiol, is combined with an anabolic androgenic agent in an aqueous vehicle having a pH of between about pH 6 to pH 8. The composition is administered to the eye in an effective amount to maintain physiologic or normal intraocular pressure or to return elevated intraocular pressure to lower levels.
机译:用于治疗由眼内压升高引起的年龄相关性黄斑病,年龄相关性黄斑变性,高眼压,青光眼或其他眼病的局部药物组合物,其包含同化雄激素剂和17-β-雌二醇的溶液悬浮或溶解于公开了合适的眼科载体。在优选的实施方案中,将17-β-雌二醇或其酯存在于脂质媒介物中,或者将17-β-雌二醇-3-磷酸酯或17-β-雌二醇的其他酯与合成代谢雄激素剂组合在一起。 pH在约pH 6至pH 8之间的水性赋形剂。以有效量将组合物施用于眼睛以维持生理或正常眼内压或使升高的眼内压恢复至较低水平。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号